Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 22;20(20):5236.
doi: 10.3390/ijms20205236.

Insights into the Pathophysiology of Infertility in Females with Classical Galactosaemia

Affiliations
Review

Insights into the Pathophysiology of Infertility in Females with Classical Galactosaemia

Zaza Abidin et al. Int J Mol Sci. .

Abstract

Classical galactosaemia (CG) (OMIM 230400) is a rare inborn error of galactose metabolism caused by the deficiency of the enzyme galactose-1-phosphate uridylyltransferase (GALT, EC 2.7.7.12). Primary ovarian insufficiency (POI) is the most common long-term complication experienced by females with CG, presenting with hypergonadotrophic hypoestrogenic infertility affecting at least 80% of females despite new-born screening and lifelong galactose dietary restriction. In this review, we describe the hypothesized pathophysiology of POI from CG, implications of timing of the ovarian dysfunction, and the new horizons and future prospects for treatments and fertility preservation.

Keywords: classical galactosaemia; fertility preservation; pathophysiology; primary ovarian insufficiency.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(a) Illustration of the pathways of galactose metabolism, with inhibition of the key enzyme: galactose-1-phosphate uridylytransferase. The key enzymes involved are shaded. (b) Illustration of the steps in oogenesis and folliculogenesis over the prenatal to menopause time period that may be influenced by GALT deficiency [16,17,18,19,20] with the proposed site of the PI3K/AKT regulation as cited by Sanchez and Smitz [20]. The abbreviations used are listed in the abbreviations list.

References

    1. Valle D., Antonarakis S., Ballabio A., Beaudet A., Mitchell G.A. The Online Metabolic and Molecular Bases of Inherited Disease. The McGraw-Hill Companies; New York, NY, USA: 2008.
    1. Wada Y., Kikuchi A., Arai-Ichinoi N., Sakamoto O., Takezawa Y., Iwasawa S., Niihori T., Nyuzuki H., Nakajima Y., Ogawa E., et al. Biallelic GALM pathogenic variants cause a novel type of galactosemia. Genet. Med. 2019;21:1286–1294. doi: 10.1038/s41436-018-0340-x. - DOI - PubMed
    1. Berry G.T. Classic Galactosemia and Clinical Variant Galactosemia. [(accessed on 10 September 2019)];Gene Rev. 2017 Available online: https://www.ncbi.nlm.nih.gov/books/NBK1518/
    1. Coss K.P., Doran P.P., Owoeye C., Codd M.B., Hamid N., Mayne P.D., Crushell E., Knerr I., Monavari A.A., Treacy E.P. Classical galactosaemia in Ireland: Incidence, complications and outcomes of treatment. J. Inherit. Metab. Dis. 2013;36:21–27. doi: 10.1007/s10545-012-9507-9. - DOI - PubMed
    1. Waggoner D.D., Buist N.R., Donnell G.N. Long-term prognosis in galactosaemia: Results of a survey of 350 cases. J. Inherit. Metab. Dis. 1990;13:802–818. doi: 10.1007/BF01800204. - DOI - PubMed

LinkOut - more resources